Rituxan (rituximab) - Roche
Thymoglobulin (anti-thymocyte globulin (rabbit)) - Sanofi
siplizumab (TCD601) - ITBMed
cyclophosphamide - Generic mfg.
fludarabine IV - Generic mfg.
Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH (clinicaltrials.gov) - Sep 29, 2026 - P1 | N=20 | Active, not recruiting | Sponsor: Massachusetts General Hospital | Trial completion date: Jun 2027 ➔ Jun 2029 | Trial primary completion date: Jan 2027 ➔ Jan 2029 
Trial completion date • Trial primary completion date
http://clinicaltrials.gov/ct2/show/NCT04540380
 
Sep 29, 2026
 
Prev Next